Paul Brannelly
2016 - Collegium Pharmaceutical
In 2016, Paul Brannelly earned a total compensation of $848.2K as Executive Vice President and Chief Financial Officer at Collegium Pharmaceutical, a 18% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $107,438 |
|---|---|
| Option Awards | $317,394 |
| Salary | $336,086 |
| Stock Awards | $78,739 |
| Other | $8,547 |
| Total | $848,204 |
Brannelly received $336.1K in salary, accounting for 40% of the total pay in 2016.
Brannelly also received $107.4K in non-equity incentive plan, $317.4K in option awards, $78.7K in stock awards and $8.5K in other compensation.
Rankings
In 2016, Paul Brannelly's compensation ranked 9,033rd out of 14,075 executives tracked by ExecPay. In other words, Brannelly earned more than 35.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,033 out of 14,075 | 36th |
Division Manufacturing | 3,491 out of 5,489 | 36th |
Major group Chemicals And Allied Products | 1,196 out of 1,895 | 37th |
Industry group Drugs | 944 out of 1,538 | 39th |
Industry Pharmaceutical Preparations | 752 out of 1,176 | 36th |
Source: SEC filing on April 13, 2017.
Brannelly's colleagues
We found five more compensation records of executives who worked with Paul Brannelly at Collegium Pharmaceutical in 2016.
2016
Michael Ph
Collegium Pharmaceutical
Chief Executive Officer
2016
Michael Heffernan
Collegium Pharmaceutical
Chief Executive Officer
2016
Michael Ph
Collegium Pharmaceutical
Founder
2016
Barry Duke
Collegium Pharmaceutical
Executive Vice President and Chief Commercial Officer
2016
Alison Fleming
Collegium Pharmaceutical